Severe SARS-CoV-2 infection and its associated hyperinflammation and cytokine activation affect insulin target tissues (primarily the liver, muscle and adipose tissue), reducing insulin sensitivity and causing hyperglycemia (33, 78). This evidence concerns the gene INS and Hyperglycemia.